Items where authors include "Yakoub-Agha, I."

Article

Styczynski, J. orcid.org/0000-0002-3158-119X, Tridello, G., Knelange, N. et al. (32 more authors) (2024) Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation, 59 (10). pp. 1402-1412. ISSN 0268-3369

Scheid, C. orcid.org/0009-0007-6539-226X, Eikema, D.-J., van Gelder, M. orcid.org/0000-0001-8698-4351 et al. (27 more authors) (2024) Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood, 144 (4). pp. 445-456. ISSN 0006-4971

Gurnari, C. orcid.org/0000-0001-6829-5544, Koster, L., Baaij, L.G.A. et al. (30 more authors) (2024) Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood Advances, 8 (6). pp. 1444-1448. ISSN 2473-9529

Pagliuca, S., Kulasekararaj, A.G., Eikema, D.-J. et al. (23 more authors) (2024) Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation. Haematologica, 109 (3). ISSN 0390-6078

Greco, R. orcid.org/0000-0002-6117-5328, Alexander, T., Del Papa, N. et al. (23 more authors) (2024) Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. eClinicalMedicine, 69. 102476. ISSN 2589-5370

Styczynski, J. orcid.org/0000-0002-3158-119X, Tridello, G., Koster, L. et al. (25 more authors) (2023) Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT. Bone Marrow Transplantation, 58 (8). pp. 881-892. ISSN 0268-3369

Rejeski, K., Subklewe, M. orcid.org/0000-0003-3905-0251, Aljurf, M. et al. (34 more authors) (2023) Immune effector cell-associated hematotoxicity (ICAHT): EHA/EBMT consensus grading and best practice recommendations. Blood Journal. 2023020578. ISSN 0006-4971

Yakoub-Agha, I. orcid.org/0000-0003-4524-8782, Greco, R. orcid.org/0000-0002-6117-5328, Onida, F. et al. (14 more authors) (2023) Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation, 58 (6). pp. 696-700. ISSN 0268-3369

Waszczuk-Gajda, A., Gras, L., de Wreede, L.C. orcid.org/0000-0002-7667-9369 et al. (22 more authors) (2023) Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—the DIADEM study from the chronic malignancies working party of the EBMT. Bone Marrow Transplantation, 58 (4). pp. 424-429. ISSN 0268-3369

Ruggeri, A., De Wreede, L.C., Müller, C.R. et al. (31 more authors) (2023) Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation. Haematologica, 108 (2). pp. 645-652. ISSN 0390-6078

Snowden, J.A. orcid.org/0000-0001-6819-3476, Sánchez-Ortega, I., Corbacioglu, S. et al. (17 more authors) (2022) Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplantation, 57 (8). pp. 1217-1239. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2022) Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplantation, 57. pp. 742-752. ISSN 0268-3369

Drozd-Sokołowska, J., Gras, L., Zinger, N. et al. (22 more authors) (2022) Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT. Bone Marrow Transplantation, 57 (4). pp. 633-640. ISSN 0268-3369

Hayden, P.J., Roddie, C., Bader, P. et al. (33 more authors) (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of Oncology, 33 (3). pp. 259-275. ISSN 0923-7534

Montoto, S., Snowden, J.A. orcid.org/0000-0001-6819-3476, Chabannon, C. et al. (19 more authors) (2022) The first steps towards a diverse and inclusive EBMT: a position paper. Bone Marrow Transplantation, 57 (3). pp. 343-346. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2021) Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplantation, 56 (7). pp. 1651-1664. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Basak, G.W. orcid.org/0000-0003-3858-8180 et al. (14 more authors) (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplantation, 54 (10). pp. 1575-1585. ISSN 0268-3369

Duarte, R.F., Labopin, M., Bader, P. et al. (19 more authors) (2019) Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant, 54 (10). pp. 1525-1552. ISSN 0268-3369

Proceedings Paper

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 708-710.

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic hematopoietic cell transplantation for Vexas syndrome: results of a multicenter study from the chronic malignancies and autoimmune disease working parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 708.